
Eureka Forbes Reports Strong FY26 Results with 11.3% Revenue Growth and 13.2% Q4 EBITDA Margin
Eureka Forbes Limited, one of India's major health and hygiene companies, today announced its financial results for the quarter and full year ended March 31, 2026. The company reported double-digit revenue growth for both the fourth quarter (Q4) and the full fiscal year (FY26), citing broad-based momentum across its product and service verticals.Strong Performance in Q4 FY26
For the quarter ended March 31, 2026, the company reported a revenue growth of 11.6% Year-over-Year (YoY). The service business continued its strong momentum, achieving double-digit growth in service bookings. The product business also saw healthy double-digit growth, driven specifically by Water Purifiers and strong performance in emerging categories.The profitability metrics showed notable improvement in Q4 FY26. The Adjusted EBITDA margin expanded 17 basis points (bps) YoY to 13.2%. Adjusted EBITDA stood at Rs 90.2 Cr, while Adjusted Profit Before Tax (PBT) increased by 8.1% YoY to Rs 73.5 Cr. Profit After Tax (pre-exceptional items) grew by 3.9% YoY to Rs 51.1 Cr.
Key figures for Q4 FY26, based on standalone results, are summarized below:
| Metric | Q4 FY26 (Rs. Cr) | Q4 FY25 (Rs. Cr) | YoY Growth |
|---|---|---|---|
| Revenue | 683.8 | 612.5 | +11.6% |
| Adjusted EBITDA | 90.2 | 79.7 | +13.1% |
| Adj. EBITDA Margin | 13.2% | 13.0% | +17 bps |
| Adj. PBT | 73.5 | 68.0 | +8.1% |
| Profit After Tax (Pre-Exceptional) | 51.1 | 49.2 | +3.9% |
Full-Year FY26 Achievements
The full year ended March 31, 2026, marked another year of structural progress for Eureka Forbes. The company delivered 11.3% revenue growth, achieving double-digit expansion for the second consecutive year.Overall performance highlights for FY26 (standalone basis) include:
- Revenue: Reported 11.3% revenue growth.
- Profitability: Adjusted EBITDA margin expanded by 55 bps to 12.2%, marking the third consecutive year of margin expansion despite increased growth investments.
- Growth Engines: Growth was powered by multiple segments, including Water Purifiers, Robotics, Softeners, and Air Purifiers.
- Net Surplus: The Net Surplus reached an all-time high of Rs 443.3 Cr.
The full-year financial performance details are presented in the table below:
| Metric | FY26 (Rs. Cr) | FY25 (Rs. Cr) | YoY Growth |
|---|---|---|---|
| Revenue | 2,710.5 | 2,436.1 | +11.3% |
| Adjusted EBITDA | 331.9 | 285.0 | +16.4% |
| Adj. EBITDA Margin | 12.2% | 11.7% | +55 bps |
| Adjusted PBT | 278.2 | 235.9 | +18.0% |
| PAT (Pre-Exceptional) | 190.2 | 159.5 | +19.3% |
| Net Surplus | N/A | N/A | N/A |
Operational and Strategic Overview
Pratik Pota, MD and CEO of Eureka Forbes Limited, commented that the company closed FY26 with solid performance despite a challenging external environment. He noted that growth was broad-based across categories, channels, and geographies, while the service bookings also grew double digits.Mr. Pota stated, "We have fundamentally reshaped the business; our transformation into a multi-category health and hygiene company is gaining strength, customer experience is improving meaningfully, and our balance sheet is significantly stronger."
The company remains focused on sustained, profitable growth. Management plans to continue driving growth through sustained investments and sharper execution, while also aggressively improving productivity by reducing inefficiencies.
The strategic growth vectors include:
- Water Purifiers: Continuing double-digit revenue growth and product penetration.
- Emerging Categories: Robust performance from Robotics, Softeners, and Air Purifiers, which are key long-term growth drivers.
- Service Business: Sustained service revenue growth momentum and improved customer experience.
Looking ahead, Eureka Forbes has articulated an ambitious goal to become a leading D2C health and hygiene technology firm, aiming for significant growth in revenue and profitability through its multi-category approach.
EUREKAFORB Stock Price Movement
Shares of Eureka Forbes Limited today slipped by 0.94% to close at ₹491.25. The stock finished the session with a total traded volume of 1.38 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.